Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 9.5.2023Cipla Europe NV (CIA-BE-2)9683AFULLHALE 25 mikrogramov/125 mikrogramov/dávka inhalačná suspenzia v tlakovom obale (sus inh 1x120 dávok (nád.tlak.Al))9.5.2023R
 9.5.2023Merck Europe B.V. (MCK-NL)31825Luveris 75 IU prášok a rozpúšťadlo na injekčný roztok (plv iol 1x75 IU (1x liek.inj.skl.-prášok+1x amp.skl.-solv.))9.5.2023O
 5.5.2023Pfizer Europe MA EEIG (PFI-BE-3)0896EVYDURA 75 mg perorálny lyofilizát (lyo por 8x1x75 mg (blis.PVC/OPA/Al) - jednotk.bal.))4.5.2023U
 5.5.2023N.V. Organon (ORG-NL)34008NASONEX (aer nau 1x18 g/140 dávok (fľ.HDPE s dávkovačom))4.5.2023O
 5.5.2023MEDOCHEMIE Ltd. (MOE)39164MEDOCLAV 1 g (tbl flm 14x1 g (blis.Al/PVC))3.5.2023O
 5.5.2023MEDOCHEMIE Ltd. (MOE)67031MEDOFLUCON 150 mg (cps dur 10x150 mg (blis.PVC/Al))3.5.2023O
 5.5.2023MEDOCHEMIE Ltd. (MOE)8859AMEDOSPIR 25 mg (tbl 100x25 mg (blis.PVC/Al))3.5.2023R
 5.5.2023MEDOCHEMIE Ltd. (MOE)96084MEDOFLUCON 150 mg (cps dur 1x150 mg (blis.PVC/Al))3.5.2023O
 4.5.2023Opella Healthcare Slovakia s.r.o. (OPL)92031Bronchicum (sol por 1x100 ml/130 g (fľ.skl.))10.1.2023Z
 4.5.2023Teva B.V. (TEV-NL-4)2870BRazagilin ratiopharm 1 mg tablety (tbl 100x1 mg (blis.Al/Al))4.5.2023O
 4.5.2023TEVA Pharmaceuticals Slovakia s.r.o. (TEV-SK)26538Sumamed forte (plv sir 1x30 ml (fľ.HDPE))8.5.2023R
 4.5.2023TEVA Pharmaceuticals Slovakia s.r.o. (TEV-SK)37070Sumamed forte (plv sir 1x15 ml (fľ.HDPE))15.5.2023R
 4.5.2023TEVA Pharmaceuticals Slovakia s.r.o. (TEV-SK)37071Sumamed forte (plv sir 1x37,5 ml (fľ.HDPE))11.5.2023R
 4.5.2023VULM s.r.o. (VUS)15620Tekutý púder s 1 % mentolu (sus der 1x100 g)1.6.2023R
 4.5.2023VULM s.r.o. (VUS)15616Tekutý púder VULM (sus der 1x100 g (fľ.PE))1.6.2023R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To